Your browser doesn't support javascript.
loading
Prognostic value of JAK3 promoter methylation and mRNA expression in clear cell renal cell carcinoma.
Long, Qian; Huang, Chunyu; Huang, Jinsheng; Meng, Qi; Cheng, Yanjun; Li, Yilin; He, Liru; Chen, Miao; Zhang, Changlin; Wang, Xiaonan; Zhu, Wancui; Peng, Jin; Shi, Dingbo; Zheng, Fufu; Dong, Pei; Deng, Wuguo.
Afiliación
  • Long Q; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Huang C; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Huang J; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Meng Q; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Cheng Y; Reproductive Center, Shenzhen Maternity & Child Healthcare Hospital, China.
  • Li Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • He L; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Chen M; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Zhang C; The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
  • Wang X; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Zhu W; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Peng J; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Shi D; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Zheng F; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Electronic address: zhengfuf@mail.sysu.edu.cn.
  • Dong P; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China. Electronic address: dongpei@sysucc.org.cn.
  • Deng W; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China. Electronic address: dengwg@sysucc.org.cn.
J Adv Res ; 40: 153-166, 2022 09.
Article en En | MEDLINE | ID: mdl-36100323
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Adv Res Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Adv Res Año: 2022 Tipo del documento: Article País de afiliación: China